الفهرس 
coverOnly 14 pages are availabe for public view
 |  | from | 183 |  |  |
| | | from | 183 | | |
Abstract
Benign prostatic hyperplasia (BPH), is one of the most
common problems of aging men, it can be associated
with bothersome lower urinary tract symptoms (LUTS) that
affect quality of life.
The range of therapeutic options for the management
of BPH continues to widen as technology continues to
evolve and improve. But when surgical treatment is
considered, transurethral resection of the prostate (TURP)
is still the gold standard.
Despite an improved safety profile with technologic
and anesthetic advances, certain significant morbidities still
occur.
Transurethral resection (TUR) syndrome is an
uncommon but potentially lifethreatening complication of
monopolar TURP in which glycine solution is used for
irrigation.